NxStage PureFlow Solution
K-Number: K233213 · 2024-01-18
ApplicantNxstage Medical, Inc.
Decision Date2024-01-18
Product CodeKPO
Advisory CommitteeGU
DecisionSubstantially Equivalent
Device Summary
NxStage PureFlow Solution is a medical device manufactured by Nxstage Medical, Inc.. It received FDA 510(k) clearance on 2024-01-18 under approval number K233213. The device is classified under product code KPO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the NxStage PureFlow Solution?
NxStage PureFlow Solution is a medical device that received FDA 510(k) clearance on 2024-01-18. It is manufactured by Nxstage Medical, Inc.. The 510(k) number is K233213.
When was NxStage PureFlow Solution approved by the FDA?
NxStage PureFlow Solution received FDA 510(k) clearance on 2024-01-18, under approval number K233213.
What company makes NxStage PureFlow Solution?
NxStage PureFlow Solution is manufactured by Nxstage Medical, Inc..
What is the FDA product code for NxStage PureFlow Solution?
The FDA product code for NxStage PureFlow Solution is KPO.
Other Devices by Nxstage Medical, Inc.
Related Devices (Code: KPO)
K160847Rockwell Medical CitraPure Acid ConcetrateRockwell Medical
K171015CitryteDi-Chem, Inc.
K162716bibagFresenius Medical Care Renal Therapies Group, LLC
K162887PrismaSATEBaxter Healthcare Corporation
K180679CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate)Global Scientific Technologies, LLC
K171750Citric Complete Dry Citric Acid (45X)Dimesol USA, LLC
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.